The Food Safety and Standards Authority of India (FSSAI) has initiated three cases against Nestlé India over alleged violations involving infant nutrition products.
Two cases concern claims made for NAN Excella Pro Stage 1 and Lactogen Pro 1, including statements about human milk oligosaccharides and whey protein.
A third case involves a follow-up formula sample that allegedly failed prescribed biotin levels even after re-testing. Nestlé has said its products comply with applicable regulations and that the claims were scientifically supported and approved by an FSSAI expert committee.
The cases will now go through the regulatory adjudication process.